Vext Science, Inc.

C$0.23As of Sun 8 Nov 2026, 12:00 UTC
CSE:VEXTHealthcare
Country Canada
PE (Fwd) •••
TSR 7Y CAGR (24.98%)
Div yield —
ROE (28.28%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.93
PE TTM —
TSR TTM (19.64%)
Mkt cap C$55.73M
ROIC (6.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.223
(0.92%)
198.27%
Hold 7|2|5|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
21.64%
22.27%
22.83%
26.47%
Revenue$M
3.976
3.912
3.951
4.017
9.58%
4.08%
2.10%
3.34%
Peers (US$39.45M)
Cap (US$)
PE
52.99M
—
39.77M
37.01x
Capital
TTM
5Y
10Y
Leveragex
0.361
0.413
0.333
EBIT/Intx
2.532
0.215
0.214
Own earn%
1196.53
(74.41)
(71.69)
Sh yield%
51.71
34.07
31.25
Owners
Insiders/Inst%
14.11
57.74
Short interest%
1.10
SBC / revenue%
4.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
33–39
$1 testx
0.1
Incr. ROIC%
2